Suicidal ideation and behavior assessment in dementia studies: An Internet survey

Phillip Chappell1, Sarah Dubrava1, Michelle Stewart1

  • 1Pfizer, Groton, CT, USA.

Abstract

Insights

Suicidal ideation and behavior assessments are useful in mild cognitive impairment and mild dementia but less reliable in severe dementia. Validated instruments are needed for accurate assessment at earlier disease stages.

Area of Science:

  • Neuroscience
  • Gerontology
  • Clinical Psychology

Background:

  • The AARR task force surveyed clinicians on suicidal ideation and behavior (SI/SB) in individuals with mild cognitive impairment (MCI) or dementia in clinical trials.
  • Assessing SI/SB in this population is crucial for patient safety and effective trial design.

Purpose of the Study:

  • To determine the extent of SI/SB in individuals with MCI or dementia participating in clinical trials.
  • To evaluate the reliability and confidence in SI/SB assessments across different stages of cognitive decline.

Main Methods:

  • An online survey was administered to investigators experienced in SI/SB assessments in MCI and dementia clinical trial subjects.
  • The survey collected data on the number of subjects assessed, the prevalence of SI/SB, and the confidence and reliability of these assessments.

Main Results:

  • While the average reported SI/SB rates were low, confidence in self-reports and the reliability of collected information decreased significantly with increasing dementia severity.
  • Approximately 70% of respondents rated information reliability as high for MCI patients, compared to less than a quarter for severe dementia patients.

Conclusions:

  • Prospective SI/SB assessments are valuable in MCI and mild dementia, but their reliability is questionable in moderate to severe dementia.
  • There is a critical need for validated assessment instruments tailored to the specific cognitive stage of patients to ensure accurate SI/SB evaluation.